Agents such as oral semaglutide, orforglipron, CagriSema, retatrutide and maridebart cafraglutide have achieved unprecedented mean weight reductions, often exceeding 15% to 20% of baseline body weight in clinical trials.37 Clinicians must keep in mind that pharmacotherapy alone is not a cure for obesity
Compare total program costs, not just medication costs
The powerful connection between B12 metabolism support and improved energy levels is why this treatment has become a cornerstone in many of our custom health and weight loss programs
We review history, medications, BMI, and order labs to determine candidacy
In other words, the lower the calcium intake, the higher the risk of developing PIH
Large-scale, prospective trials are needed to confirm its long-term safety and efficacy